Using Modelling to Inform Public Health Impact in the HIV Response

Value of the Information & Strength of the Argument

The seminar provides valuable insights into the practical application of mathematical modeling for HIV policy. The speaker demonstrates the utility of modeling in estimating the impact of funding cuts and in evaluating combination prevention strategies. The argumentation is solid, based on specific case studies and published research. The speaker clearly explains the methods and limitations, such as the short-term nature of projections and the need for uncertainty analysis. The emphasis on capturing heterogeneity and key populations is well-justified with examples. The presentation is persuasive in advocating for modeling as a central tool for decision-making, supported by concrete evidence and real-world applications.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high, with references to peer-reviewed publications (e.g., in Lancet HIV) and systematic reviews. The speaker uses data from global reports (UNAIDS) and collaborates with international networks. The methods are described with transparency, including parameterization and calibration. The title accurately reflects the content, focusing on the use of modeling to inform public health impact. The presentation is well-structured and aligns with the stated objectives. No comments were provided for analysis.

The title accurately reflects the content, which focuses on the application of mathematical modeling to inform HIV public health decisions, with case studies and a translation pipeline.

8/10

The seminar is presented by a senior research associate with extensive experience in HIV modeling and policy. It references specific published studies (e.g., in Lancet HIV) and uses data from systematic reviews and global reports. The methods are described with transparency, and the speaker acknowledges limitations. However, some claims lack direct citations in the presentation, and the content is largely based on the speaker's own work and perspective.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 02:00Introduction to the seminar and speaker's background.
• 05:00Overview of the University of Bristol's global epidemiology and modeling group.
• 10:00Discussion on why HIV modeling matters and current progress.
• 15:00Importance of capturing heterogeneity in HIV models, with example on homelessness.
• 20:00Focus on key populations and their role in HIV transmission.
• 25:00Explanation of the 'modelling-to-meaning' pipeline.
• 30:00Case study: impact of PEPFAR funding cuts on PrEP in sub-Saharan Africa.
• 35:00Case study: impact of funding cuts on OAT and NSP for people who inject drugs.
• 40:00Dynamic compartmental models for combination prevention in South Africa and Kenya.
• 45:00Emerging challenges and opportunities in HIV response.

• Lancet HIV publication on PEPFAR funding cuts and PrEP — Mentioned as a recent study led by the speaker and colleagues on the impact of ceasing PEPFAR-funded PrEP.
• UNAIDS data on new HIV infections — Referenced for global and regional HIV incidence data.

• UNAIDS Global AIDS Update 2024 — Provides global data on HIV incidence and progress towards targets, consistent with the seminar's claims.
• WHO HIV policy guidance — Supports the role of modeling in informing WHO guidance, as mentioned by the speaker.

• Potential overestimation of funding cut impacts — Some critics might argue that static models may overestimate short-term impacts by not accounting for behavioral adaptations or alternative funding sources.